Therapeutic Index

Therapeutic Index designates a quantitative measure comparing a drug's toxic dose to its effective dose, representing the safety margin between therapeutic benefit and harmful effects, commonly expressed as the ratio of median toxic dose to median effective dose. This fundamental pharmacology concept guides dose selection, risk assessment, and clinical monitoring, with higher therapeutic indices indicating safer drugs allowing wider dosing flexibility, while narrow therapeutic index drugs require careful dosing and patient management.

The biopharmaceutical industry considers therapeutic index throughout drug discovery and development, as safety margins strongly influence clinical viability and regulatory acceptance. Narrow therapeutic index drugs including warfarin, digoxin, lithium, and certain immunosuppressants require precise dose control and therapeutic drug monitoring, as small dose changes can cause toxicity or loss of efficacy. Clinical trials establish exposure-response relationships identifying concentrations associated with benefit versus adverse events, informing dosing recommendations and label warnings. Pharmacokinetic variability across patients, drug-drug interactions, organ impairment, and genetic differences affecting metabolism can narrow effective safety margins. Formulation strategies including controlled-release systems can improve therapeutic index by reducing peak-related toxicity. As precision medicine advances enabling individualised dosing and biomarker-guided monitoring, therapeutic index remains central for balancing efficacy and safety.